Drugs / Umbilical Cord Lining Stem Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04723303 | Oct 2021 → Dec 2023 | dermatomyositis | University of Florida | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Umbilical Cord Lining Stem Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04723303 ↗ |
| Known as | ULSC | “Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product” NCT04723303 ↗ |
| Modality | Cell therapy | “allogeneic umbilical cord lining stem cells (ULSC)” NCT04723303 ↗ |
| Route | Intravenous | “a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells (ULSC)” NCT04723303 ↗ |